{
  "case_id": "case_0024",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 45.82,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "Middle Eastern / North African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\n  \nSome more precision is possible than: 'right mid-thoracic spinal cord'.  \nNamely, in the region of: right T5 spinal cord.\n  \nSome more precision is possible than: 'right optic nerve'.  \nNamely, in the region of: bilateral optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "right T5 myelopathy",
          "bilateral optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "mid-thoracic spinal cord",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [],
        "imprecise_matches": [
          [
            "right mid-thoracic spinal cord",
            [
              "right T5 myelopathy"
            ]
          ],
          [
            "right optic nerve",
            [
              "bilateral optic nerve (cranial nerve II)"
            ]
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 0,
        "imprecisely_identified_count": 2,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 0.0,
        "proportion_imprecise": 1.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE, Neurosyphilis and Lyme.\n\nOther possible differentials:\n- Feasible but of low probability: Vasculitis, ADEM and Beh\u00e7et's.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Idiopathic acute transverse myelitis (plausible for unilateral spinal cord; but atypical for bilateral optic nerve involvement)\n- Spinal cord compression from tumour or epidural abscess (plausible for unilateral spinal cord; but atypical for bilateral optic nerve involvement)\n- Vitamin B12 deficiency (subacute combined degeneration of the cord) (plausible for bilateral optic nerve; but atypical for unilateral spinal cord involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple sclerosis",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG-antibody-associated disease",
          "Idiopathic acute transverse myelitis",
          "Spinal cord compression from tumour or epidural abscess",
          "Systemic autoimmune disease\u2013associated myelitis (e.g. systemic lupus erythematosus, Sj\u00f6gren's syndrome, neurosarcoidosis)",
          "Vitamin B12 deficiency (subacute combined degeneration of the cord)",
          "Infectious myelitis (e.g. HIV, syphilis, Lyme disease)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MOGAD",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "Autoimmune_Myelitis_SLE",
          "Infection_Lyme"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Vasculitis",
          "ADEM",
          "Behcet_Disease"
        ],
        "missing_common_names": [],
        "missing_low_prob_names": [
          "Vasculitis",
          "ADEM",
          "Beh\u00e7et's"
        ],
        "additional_diagnoses": [
          "Idiopathic acute transverse myelitis",
          "Spinal cord compression from tumour or epidural abscess",
          "Vitamin B12 deficiency (subacute combined degeneration of the cord)"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 3,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 10,
        "lesion_ddx_matched_count": 7,
        "lesion_ddx_missed_common_count": 0,
        "lesion_ddx_missed_low_prob_count": 3,
        "lesion_ddx_coverage_percentage": 0.7
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Cervical Spine, Brain, Thoracic Spine and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, ENA, ACE, anti-AQP4, syphilis, ESR.\n- Could also consider testing: anti-dsDNA, ANCA, lyme.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain, orbits and whole spine with gadolinium",
          "Lumbar puncture with CSF cell count, protein, glucose, culture, cytology and oligoclonal bands",
          "Visual evoked potentials",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Vitamin B12 level",
          "Folate level",
          "Thyroid function tests",
          "Serum aquaporin-4 IgG antibody",
          "Serum MOG-IgG antibody",
          "Antinuclear antibody (ANA)",
          "Extractable nuclear antigen (ENA) panel including anti-Ro and anti-La",
          "Serum angiotensin converting enzyme (ACE)",
          "HIV serology",
          "Syphilis serology (VDRL/TPPA)",
          "Serum copper level",
          "Serum protein electrophoresis and immunofixation",
          "Urinalysis",
          "Chest CT or PET-CT if sarcoidosis or malignancy suspected on initial tests"
        ],
        "all_identified_ft_keys": [
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Blood_Cultures",
          "Syphilis_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Whole_Spine",
          "Serum_Copper",
          "Serum_Protein_Electrophoresis",
          "Chest_CT",
          "MRI_Lumbosacral_Spine",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "MRI_Thoracic_Spine",
          "Urinalysis",
          "HIV_Test",
          "CSF_Cytology",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "ANCA",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 5,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 11,
        "ddx_tests_found_count": 8,
        "ddx_tests_coverage_percentage": 0.7272727272727273
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Standard first-line therapy for acute demyelinating optic neuritis and myelitis",
              "Aims to hasten visual and motor recovery and limit cord damage",
              "Systemic infection appears unlikely given normal temperature, CRP and WCC"
            ]
          },
          {
            "treatment": "Oral prednisolone taper for 2\u20134 weeks following IV steroids",
            "timing": "Delay",
            "reasons": [
              "Commence after completion of IV pulse to prevent rebound symptoms",
              "Dose and duration adjusted according to response and final diagnosis"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges over 10\u201314 days)",
            "timing": "Delay",
            "reasons": [
              "Reserved for severe or rapidly progressive deficits not improving within several days of IV steroids",
              "Particularly important if NMOSD or MOG-antibody-associated disease is confirmed or strongly suspected"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for multiple sclerosis (e.g. ocrelizumab or other high-efficacy agent as per local protocol)",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic criteria for MS are fulfilled on MRI and CSF",
              "Requires exclusion of NMOSD/MOGAD and assessment of comorbidities and infection risk",
              "Needs detailed counselling and shared decision-making"
            ]
          },
          {
            "treatment": "Long-term immunosuppressive therapy for NMOSD (e.g. rituximab, satralizumab or inebilizumab) if NMOSD confirmed",
            "timing": "Delay",
            "reasons": [
              "Choice of agent depends on AQP4 status and specialist input",
              "Started only once NMOSD diagnosis is secure because some MS therapies can worsen NMOSD"
            ]
          },
          {
            "treatment": "Physiotherapy and gait rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Right leg weakness and spasticity are already impairing gait and balance",
              "Early mobilisation reduces deconditioning and promotes neuroplastic recovery"
            ]
          },
          {
            "treatment": "Deep vein thrombosis prophylaxis with low-molecular-weight heparin and compression stockings",
            "timing": "Start Now",
            "reasons": [
              "Lower-limb weakness and reduced mobility increase venous thromboembolism risk",
              "Prophylaxis is recommended in acute myelopathy until mobility improves"
            ]
          },
          {
            "treatment": "Neuropathic pain management with agents such as gabapentin or amitriptyline if sensory symptoms are painful",
            "timing": "Start Now",
            "reasons": [
              "Band-like chest dysaesthesia and limb paraesthesia can be distressing and limit rehabilitation",
              "Early symptom control improves sleep, mood and participation in therapy"
            ]
          },
          {
            "treatment": "Gastric protection with a proton pump inhibitor during high-dose steroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroids increase risk of gastritis and peptic ulceration",
              "Patient will receive several days of IV and oral steroids"
            ]
          },
          {
            "treatment": "Vitamin D supplementation and lifestyle advice (smoking cessation, exercise) if demyelinating disease confirmed",
            "timing": "Delay",
            "reasons": [
              "Supportive long-term measures that may modify disease course in MS",
              "Can be initiated electively after diagnosis and baseline levels are checked"
            ]
          },
          {
            "treatment": "Occupational therapy assessment and home safety review",
            "timing": "Delay",
            "reasons": [
              "Plan once early response to treatment is known and residual deficits are clearer",
              "Aims to optimise independence and reduce falls risk if gait impairment persists"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Standard first-line therapy for acute demyelinating optic neuritis and myelitis",
              "Aims to hasten visual and motor recovery and limit cord damage",
              "Systemic infection appears unlikely given normal temperature, CRP and WCC"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for multiple sclerosis (e.g. ocrelizumab or other high-efficacy agent as per local protocol)",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic criteria for MS are fulfilled on MRI and CSF",
              "Requires exclusion of NMOSD/MOGAD and assessment of comorbidities and infection risk",
              "Needs detailed counselling and shared decision-making"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 2,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.6666666666666666
        }
      }
    }
  }
}